Biogen/Eisai Win On Aduhelm Approval Bet And Wager Next On Price

 
• By Jessica Merrill
  
betting
Biogen's big bet on aducanumab made it across the finish line • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip